НЕЙТРОФИЛЫ ПРИ ГЛОМЕРУЛОНЕФРИТЕ
https://doi.org/10.24884/1561-6274-2005-9-2-30-41
Аннотация
Нейтрофилы при гломерулонефрите.
Об авторе
Т. В. Абрамова
Научно-исследовательский институт экспериментальной медицины РАМН
Россия
Россия
Отдел общей патологии и патофизиологии
Список литературы
1. Тареева ИЕ. Механизмы прогрессирования гломеру лонефрита. Тер арх 1988; (6): 37
2. Dixon FJ, Feldman JD, Vazques JJ. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med 1961; 113(2):899920
3. Альбини Б, Брентьенс ЯР, Андрес ДА. Иммунопатоло гия почки. Медицина, М., 1982; 264
4. Theofilopoulos AN, Dixon FJ. The biology and detection of immune complexes. In: Advances in immunology. Ed. FJ Dixon, New York, 1979; 28: 89220
5. Шилов ЕМ. Иммунопатология болезней почек. В: Та реева ИЕ, ред. Нефрология. Руководство для врачей. Ме дицина, М., 2000; 132144
6. Шулутко БИ. Концепция гломерулонефрита как нозо ологии. Нефрология 2002; 6(2): 102108
7. Шулутко БИ. Нефропатии как сосудистая патология. Нефрология 2003; 7(4): 2128
8. Мухин НА. Комментарии к разделам, написанным Е.М.Тареевым. В: Тареева ИЕ, ред. Нефрология. Руковод ство для врачей. Медицина, М., 2000; 205210
9. Johnson R, Klebanoff SJ, Couser WG. Cellular mediators of immune injury: Neutrophils. In: Neilson EG, Couser WG. Immunologic Renal Diseases, LippincottRaven, Philadelphia, 1997; 547560
10. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and the therapeutic studies. J Am Soc Nephrology 2003; 14: 338351
11. Schrijver G, Bogman JJT, Assmann KJM et al. Anti GBN nephritis in the mouse: role of granulocytes in the heterologous phase. Kidney Int 1990; 38: 8695
12. Noris M, Remuzzi G. New insights into circulating cell endothelium interaction and their significance for glomerular pathophysiology. Am J Kidney Dis 1995; 26(3): 541548
13. Isha N, Cashman SJ, Hay H et al. Modulation of antibody mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor and Il1. J Immunol 1989; 142: 30803090
14. Ohse T, Ota T, Kieran N et al. Modulation of interferon induced genes by lipoxin analogue in antiglomerular basement membrane nephritis. J Am Soc Nephrol 2004; 15(4): 919927
15. O’Meara YM, Brady HR. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. Kidney Int [Suppl] 1997; 58: S5661
16. McMahon B, Mitchel S, Braly HR, Godson C. Lipoxins: Revelations in resolution. TiPS 2001; 22: 391395
17. Papayianni A, Serhan CN, Philips ML et al. Transcellular biosynthesis of Lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. Kidney Int 1994; 47: 12951302
18. Mayadas TN, Mendrick DL, Brady HR et al. Acute passive antiglomerular basement membrane nephritis in Pselectin deficient mice. Kidney Int 1996; 49: 13421349.
19. Munger KA, Montero A, Fukunago M et al. Transfection of rat kidney with human 15lipoxygenase supresses inflammation and preserves function in experimental glomerulonephritis. Proc Natl Acad Sci USA 1999; 96: 13375 13380
20. Papayianni A, Serhan CN, Brady HR. Lipoxin А4 and В4 inhibit leukotrienestimulated interaction of human neutrophils and endothelial cells. J Immunol 1996; 156: 22642272.
21. Donovan KL, Coles GA, Williams JD. Tumor necrosis factorб augments the proinflammatory interaction between PMN and GBN via a CD18 dependent mechanism. Kidney Int 1995; 48: 698704
22. Harada A, Sekido N, Akahoshi T et al. Essential involvement of interleukin8 (Il8) in acute inflammation. J Leukocyte Biol 1994; 56(5): 559564
23. Peichl P, Ceska M, Broell H et al. Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. Annals Rheum Dis 1992; 51: 1922
24. Yoshioka K, Takemura T, Murakami K et al. In situ expression of cytokine in IgA nephropathy. Kidney Int 1993; 44: 825833
25. Li HL, Hancock WW, Hooke DH et al. Mononuclear cell activation and decreased renal function in IgA nephropathy with crescents. Kidney Int 1990; 37: 15521556
26. Matsumoto K. Effect of various cytokines, lipopolysaccharides, and soluble immune complexes on the release of interleukin8 by monocytes from patients with IgA nephropathy (letter). Nephron 1995; 69: 352353
27. Chen HC, Tomino Y, Yaguchi Y et al. Oxidative metabolism of polymorphonuclear leukocytes (PMN) in patients with IgA nephropathy. J Clin Lab Analysis 1992; 6 (1): 3539
28. Wada T, Yokoyama H, Tomosugi N et al. Detection of urinary interleukin8 in glomerular diseases. Kidney Int 1994; 46: 455460
29. Saleem S, Dai Z, Coelho SN et al. IL4 is endogenous inhibitor of neutrophil influx and subsequent pathology in acute antibodymediated inflammation. J Immunol 1998; 160: 979 984
30. Werteim WA, Kunkel SL, Standiford TJ et al. Regulation of neutrophilderived IL8: the role of prostaglandin E2, dexamethasone, and IL4. J Immunol 1993; 151: 21662171
31. Feng L, Xia Y, Yoshimura T, Wilson CB. Modulation of neutrophil influx in glomerulonephritis in the rat with anti macrophage inflammatory protein2 (MIP2) antibody. J Clin Invest 1995; 95:10091017
32. Wu X, Dolecki GJ, Sherry B et al. Chemokines are expressed in a myeloid celldependent fashion and mediate distinct functions in immune complex glomerulonephritis in rat. J Immunol 1997; 158: 39173924
33. Wu X, Helfrich MH, Horton Ma et al. Fibrinogen mediates plateletpolymorphonuclear leukocyte cooperation during immunecomplex glomerulonephritis in rat. J Clin Invest 1994; 94(3): 982936
34. Matsuda M, Shikata K, Makino H et al. Glomerular expression of macrophage colonystimulating factor and granulocytemacrophage colonystimulating factor in patients with various forms of glomerulonephritis. Lab Invest 1996; 75: 403412
35. Kitching AR, Huang XR,. Turner AL et al.The requirement for granulocytemacrophage colonystimulating factor and granulocyte colonystimulating factor in leukocytemediated immune glomerular injuri. J Am Soc Nephrol 13: 350358, 2002.
36. Magen D, Mandel H, Berant M et al. MPGN type I induced by granulocyte colony stimulating factor. Pediatr Nephrol 2002; 17(5): 370372.
37. Klein JB, Rane MJ, Scherzer JA et al. Granulocyte macrrophage colonystimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3kinase and extracellular signalregulated kinase pathways. J Immunol 2000; 164: 42864291
38. Huang XR, Holdsworth SR, Tipping PG. Th2 responses induce humorally mediated injury in experimental anti glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 1997; 8: 11011108
39. Asghar SS, Pasch MC. Therapeutic inhibition of the complement system. Front Biosci 2000; 1(5): E6381
40. Sheerin NS, Springall T, Carrol Mc et al. Protection against antiglomerular basement membrane (gbm)mediated nephritis in C3 and C4 deficient mice. J Clin Exp Immunol 1997; 110(3): 403409
41. Robson MG, Cook HT, Pusey CD et al. Antibody mediated glomerulonephritis in mice: the role of endotoxin, complement and genetic background. Clin Exp Immunol 2003; 133(3): 326333
42. Kokubo T, Hiki Y, Iwase H et al. Evidence for involvement of IgA1 hinge glycopeptide in IgA1IgA1 interaction in IgA nephropathy. J Am Soc Nephrol 1997; 8: 915919
43. Hiki Y, Kokubo T, Iwase H et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 1999; 10: 760769
44. Kokubo T, Hiki Y, Iwase H et al. Protective role of IgA1 glycans against IgA1 selfaggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 1998; 9: 2048 2054
45. Сoppo R, Amore A, Gianoglio B et al. Serum IgA and macromolecular IgA reacting with mesangial matrix components. Contr Nephrol 1993;104: 162171
46. Sano T, Hiki Y, Kokubo T, Iwase H et al. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Nephrol Dial Transplant 2002; 17: 5056
47. Зайчик АШ, Чурилов ЛП. Основы общей патологии. ЭЛБИСПб, СПб, 1999; 297302
48. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. ELAM1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1988; 243: 11601164
49. Tipping PG, Huang XR, Berndt MC, Holdsworth SR. A role of Pselectin in complementindependent neutrophil mediated glomerular injury. Kidney Int 1994; 46: 7988
50. Zachem CR, Alpers CE, Way W et al. A role for P selectin in neutrophil and platelet infiltration in immune complex glomerulonephritis. J Am Soc Nephrol 1997; 8: 18381844
51. Ito I, Yuzawa Y, Mizuno M et al. Effects of a new synthetic selectin blocker in an acute rat thrombotic glomerulonephritis. Am J Kidney Dis 2001; 38: 265273
52. De Vriese AS, Endlich K, Elger M et al. The role of selectins in glomerular leukocyte recruitment in rat anti glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 10: 25102517, 1999
53. Rosenkranz AR, Mendrick DL, Cotran RS, Mayadas TN. Pselectin deficiency exacerbates experimental glomerulonephritis: A protective role for endothelial Pselectin in inflammation. J Clin Invest 1999; 103: 649659
54. Gamble JR, Skinner MP, Berndt MC, Vadas MA. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science 1990; 249: 414417
55. Lai KN, Wong KC, Li PKT et al. Circulating leukocyte endothelial adhesion molecules in IgA nephropathy. Nephron 1994; 68: 294300
56. Lai KN. Future directions in the treatment of IgA nephropathy. Nephron 2002; 92(2): 263270
57. Шубич МГ, Авдеева МГ, Вакуленко АД. Адгезивные меж клеточные взаимодействия. Арх патологии 1997; 59(6): 39
58. Xu H, Gonzalo J, Pierre Y et al. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1deficient mice. J Exp Med 1994; 180: 95102
59. Canton D. Adhesion molecules in renal disease. Kidney Int 1995; 48: 16871698
60. Lefkowith JB. Leukocyte migration in immune complex glomerulonephritis: role of adhesion receptors. Kidney Int 1997; 51: 14691475
61. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD16. Blood. 1990; 75: 10371050
62. Zhou MJ, Todd III RF, van de Winkel GJ, Petty HR. Co capping of the leukoadhesion molecules complement receptor type 3 and lymphocyte functionassociated antigen1 with Fcг receptor III on human neutrophils. J Immunol 1993; 150: 3030 3041
63. Wu X, Pippin J, Lefkowith JB. Attenuation of immune mediated glomerulonephritis with an antiCD11b monoclonal antibody. Am J Physiol 1993; 264: F715F721
64. Mulligan MS, Johnson KJ, Todd III RF et al. Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 1993; 91: 577587
65. Suzuki Y, GomezGuerrero C, Shirato I et al. Preexisting glomerular immune complexes induce polymorphonuclear cell recruitment through an Fc receptordependent respiratory burst: potential role in the perpetuation of immune nephritis. J Immunol 2003; 170: 32433253
66. Wakayama H, Hasegawa Y, Kawabe T et al. Abolition of antiglomerular basement membrane antibodymediated glomerulonephritis in Fcгdeficient mice. Eur J Immunol 2000; 30(4): 11821190
67. Tang BT, Rosenkranz A, Assmann KJM et al. A role for Mac1 (CDIIb/CD18) in immune complexstimulated neutrophil function in vivo: Mac1 deficiency abrogates sustained Fcг receptordependent neutrophil adhesion and complement dependent proteinuria in acute glomerulonephritis. J Exp Med 1997; 186(11): 1853 –1863
68. Radeke HH, JanssenGraalfs I, Sowa EN et al. Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti glomerular basement membrane (GBM) nephritis. J Biol Chem 2002; 277(30): 2753527544
69. Kashem A, Endoh M, Nomoto Y et al. Fcб R expression on polymorphonuclear leukocyte and superoxide generation in IgA nephropathy. Kidney Int 1994; 45: 868875
70. Kashem A, Endoh M, Yano N et al. Glomerular FcбR expression and disease activity in IgA nephropathy. Am J Kidney Dis 1997; 30: 389396
71. Fujigaki Y, Nagase M, Kojima K et al. Glomerular handling of immune complex in the acute phase of active in situ immune complex glomerulonephritis employing cationized ferritin in rats. Ultrastructural localization immune complex, complements and inflammatory cells. Virchow’s Archiv 1997; 431(1): 5361
72. Ihm CG, Woo JT, Chang YW et al. Immunological abnormalities in patient with IgA nephropathy. J Korean Med Sci 1986; 1: 4348
73. Мирошниченко НГ. Изменение фагоцитарного ин декса у больных хроническим гломерулонефритом. Врачеб ное дело 1979; 9:3638
74. Мирошниченко НГ, Полянцева ЛР, Козловская ЛВ. Фагоцитарная активность лейкоцитов крови у больных хро ническим гломерулонефритом. Тер архив 1980; 4: 3135
75. Ефремова НБ, Быкова ВА, Козловская ЛВ. Метод оценки резервной активности полиморфноядерных лейко цитов (ПЯЛ) у больных хроническим гломерулонефритом. I съезд нефрологов России (тезисы докладов). Казань; 1994: 15.
76. Козловская ЛВ, Коррыева БЧ, Артемьева ВБ. Вос палительные механизмы активности нефрита. 5 Пленум со юзной проблемной комиссии «нефрология», 14 16 мая 1990. Тезисы докладов. Фрунзе, 1990: 37
77. Westerhuis R, van Straaten SC, van Dixhoorn MGA et al. Distinctive roles of neutrophils and monocytes in AntiThi1 nephritis. Am J Pathol 2000; 156(1): 303310
78. Baund L, Fouqueray B, Philippe C, Ardaillou R. Reactive oxygen spicies as glomerular autacoids. J Am Soc Nephrol 1992; 2: 132138
79. Shah SV. The role of reactive oxygen metabolites in glomerular disease. Ann Rev Physiol 1995; 57: 245262
80. Yoshioka T, Ichikawa I. Glomerular dysfunction induced by polymorphonuclear leukocytederived reactive oxygen species. Am J Physiol 1989; 257: F53F59
81. Johnson RL, Guggenhein SJ, Klebanoff SJ et al. Morphologic correlates of glomerular oxidant injury induced by the myeloperoxidasehydrogen peroxide – halide system of the neutrophil. Lab Invest 1988: 58: 294301
82. Poelstra K, Hardonk MJ, Koudstaal J, Bakker WW. Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int 1990; 37(6): 15001508
83. Ventura MT, Gesualdo L, Capobianco V et al. Effects of in vitro nutrient supplementation on polymorphonuclear cell respiratory burst in primary IgA nephropathy. Clin Nephrology 1995; 43(1): 1419
84. Chen HC, Guh JY, Chang JM, Lai YH. Differential effects of FMLPactivated neutrophils from patients with IgA nephropathy enhanced endothelin 1 production of glomerular mesangial cells. Nephron 2001; 89: 274279
85. Lai KN, Leung JSK, Li PKT. Heat aggregated IgA prepared from patients with IgA nephropathy increases priming of human neutrophils to produce inositol triphosphate following FMLP stimulation in vitro. Nephron 1995; 69:18
86. Lai KN, Leung JSK. Heat aggregated IgA prepared from patients with IgA nephropathy increases calcium mobilization and superoxide production of human neutrophils in vitro. Nephron 1993; 64:129135
87. Сейсембеков ТЗ, Айтпаев БК, Муравлева ЛЕ. Пока затели свободнорадикального окисления и функциональ ного состояния нейтрофилов при хронических заболеваниях почек и токсических нефропатиях. 5 Пленум союзной про блемной комиссии «нефрология». 14 16 мая 1990. Тезисы докладов. Фрунзе, 1990: 43
88. Жмуров ВА, Малишевский МВ, Гапон ЛИ, Мельни ков АН. Дестабилизация липидной фазы мембран нейтро филов у больных гипертонической формой хронического гломерулонефрита. I съезд нефрологов России (тезисы док ладов). Казань; 1994: 16
89. Малишевский МВ, Жмуров ВА, Гапон ЛИ и др. Нару шения функциональнометаболической активности поли морфноядерных лейкоцитов у больных гипертонической формой хронического гломерулонефрита в зависимости от морфологической картины. Сборник Клиническая морфо логия в нефрологии. СПб 1994: 9394
90. Кокряков ВН. Биология антибиотиков животного происхождения. Наука, СПб., 1999; 162.
91. Matzner Y, Bar NM, Yahalom J et al. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils: Possible role in invasion through basement membranes. J Clin Invest 1985; 76: 13061313
92. Hruby Z, Wendycz D, Kopec W et al. Mechanism of antinephritic effect of proteinase inhibitors in experimental anti GBM glomerulopathy. Res Exp Med 2000; 199(5): 295307
93. Janoff A. Neutrophil proteases in inflammation. Ann Rew Medicine 1972; 23: 177190
94. Janoff A. Elastase in tissue injury. Ann Rew Medicine 1985; 36: 207216
95. Travis J, Savesen GS. Human plasma proteinase inhibitors. Ann Rev Biochem 1983; 52: 655709
96. McIntyre TM, Zimmerman GA, Prescott SM. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize plateletactivating factor and bind neutrophis. Proc Natl Acad Sci USA 1986; 83: 22042208
97. Yared A, Albrightson WC, Griswold D et al. Functional significance of leukotriene B4 in normal and glomerulonephritic kidneys. J Am Soc Nephrol 1991; 2: 4556
98. Heeringa P, van Goor H, Itonlindstrom Y, Maeda N. Lack of endothelial nitric oxide synthase aggravates murine accelerated antiglomerular basement membrane glomerulonephritis. Am J Pathol 2000; 156(3): 879888
99. Oda T, Hotta O, Taguma Y et al. Involvement of neutrophil elastase in crescentic glomerulonephritis. J Human Pathology 1997; 28(6): 720728
100. KincaidSmith P, Nicholls K, Birchall I. Polymorphs infiltrate glomeruli in mesangial IgA glomerulonephritis. Kidney Int 1989; 36(6): 1108 – 1111
101. Lai KN, Shute J, Lindley I et al. Neutrophil attractant protein1/Interleukin 8 and its autoantibodies in IgA nephropathy. Clin Immunol Immunopathol 1996; 80: 4754
102. Savill J, Smith J, Sarraf C et al. Glomerular mesangial cells and inflammatory macrophages ingest neutrrophils undergoing apoptosis. Kidney Int 1992; 42(4): 924936
103. Hughes J, Johnson RJ, Mooney A et al. Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis. Am J Pathol 1997; 150(1): 223234
104. Savill J, Fadok VA. Corpse clearance defines the meaning of cell death. Nature 2000; 407: 784787
105. Taylor PR, Carugati A, Fadok VA et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000; 192: 33593366
106. Takazoe K, Tesch GH, Hill PA et al. CD44mediated neutrophil apoptosis in the rat. Kidney Int 2000; 58(5): 1920 1930
107. Nath KA, Croatt AJ, Hostetter TN. Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol 1990; 258: F1354F1362
108. Trachtman B, Schwob N. Administration of vitamin E attenuates chronic puromycin aminonucleoside nephropathy (abstract). J Am Soc Nephrol 1993; 4: 785
109. Ward KP, Kuemmerle NB, Krieg RJ et al. Indices of progression of IgA nephropathy are modulated by бtocopherol in rats. Clin Exp Nephrol 2000; 4: 187192
110. Carla Z, Remuzzi G. Coagulation and thrombosis in immunologic renal disease. Immunol Renal Dis 1996; 1: 489 499
111. Pollak VE. Glomerular thrombosis predicts progression of glomerulonephritis: Can we prevent progression? Am J Kidney Dis 1995; 26: 535540
112. Rosenberg RD, Aird WC. Vascularbedspecific hemostasis and hypercoagulable states. N Engl J Med 1999; 340: 15551564
113. Mizutani M, Yuzawa Y, Maruyama I et al. Glomerular localization of trombomodulin in human glomerulonephritis. Lab Invest 1993; 69:193202
114. Ikeguchi H, Maruyama S, Morita Y et al. Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int 2002; 61: 490501
115. Stambe C, Atkins RC, Tesch GH et al. Blockade of p38a MAPK ameliorates acute inflammotory renal injury in rat antiGBM glomerulonephritis. J Am Soc Nephrology 2003; 14: 338351
116. Koizumi R, Kanai H, Maezawa A et al. Therapeutic effects of ulinastatin on experimental crescentic glomerulonephritis in rats. Nephron 2000; 84(4): 347352
Рецензия
Для цитирования:
Абрамова Т.В. НЕЙТРОФИЛЫ ПРИ ГЛОМЕРУЛОНЕФРИТЕ. Нефрология. 2005;9(2):30-41. https://doi.org/10.24884/1561-6274-2005-9-2-30-41
For citation:
Abramova T.V. NEUTROPHILS IN GLOMERULONEPHRITIS. Nephrology (Saint-Petersburg). 2005;9(2):30-41. (In Russ.) https://doi.org/10.24884/1561-6274-2005-9-2-30-41
Просмотров: 240
Послать статью по эл. почте 